U.S. Marine and Shipping Stock News

Weaker earnings and declining revenue at Papa John's International (PZZA) have drawn investor attention to the stock. The latest results highlight questions around demand, efficiency, and the health of its franchise system. See our latest analysis for Papa John's International. The recent quarterly miss comes after a mixed period for Papa John's International, with the share price up 4.92% over the last day but down 10.04% over three months and the 1 year total shareholder return declining...

Darden Restaurants was recently highlighted for strong profit growth, efficient capital use, disciplined debt management, and dependable cash generation, underscoring the resilience of its restaurant portfolio. This focus on maintaining a high operational and quality bar across its brands reinforces Darden’s reputation for running a robust, efficiency-driven casual dining model. Next, we’ll examine how Darden’s disciplined debt management and reliable cash generation shape the company’s...

RH recently launched RH Estates at the ultra-high end of home design, opened RH London, The Gallery in Mayfair, and entered a multi-year collaboration with the Mercedes-AMG PETRONAS Formula One Team to curate luxury interiors across the team’s global hospitality footprint. Together, these moves push RH deeper into the global luxury ecosystem by combining ultra-premium product lines, a flagship presence in a top European fashion district, and exposure to affluent Formula One audiences. We’ll...

Xylem stock has delivered a 14.5% gain over the past three years. At around US$125 per share, the valuation picture now looks closer to fair than clearly cheap, with the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples both pointing to pricing that is roughly in line with the fundamentals. Over the last three years, Xylem shares are up 14.5%, which is a solid but not spectacular return for investors who have stayed in the stock. Future cash flow growth from Xylem's...

PJT Partners has delivered a very strong 142.3% share price return over the past five years, yet the stock now screens as only fairly valued on an intrinsic value basis while still looking inexpensive on some earnings multiples and carrying a low overall value score. The 142.3% return over five years highlights how much of PJT Partners' earlier upside has already been realised, so fresh gains may depend on whether earnings and cash flows keep pace with expectations. Recent headlines around...

Becton Dickinson stock has fallen around 18% over the past three years, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach currently points to meaningful upside relative to the market price, leaving investors to weigh that signal against a more mixed overall valuation score. The share price decline of about 18% over three years raises the question of whether the recent weakness has already accounted for the key risks, or if it reflects deeper concerns about long...

The Simply Good Foods Company recently reported that third-quarter fiscal 2026 sales fell to US$356.98 million from US$380.96 million a year earlier, with the business moving from a US$41.10 million net profit to a US$51.97 million net loss and posting losses for the first nine months as well. Alongside these weaker results, management cut net sales guidance for both the fourth quarter and full fiscal 2026, even as it completed a multi-year buyback that retired 16.11% of shares for US$344.93...

The Eli Lilly move on AtaiBeckley has pushed psychedelics and mental health treatments back into the spotlight, and it is giving investors fresh reasons to reassess which stocks are most exposed to this news. With a multi billion dollar cash deal, a premium offer, and a late stage DMT program now under a big pharma umbrella, attention is turning to other companies tied to similar themes. This article breaks down three stocks from our mental health and psychedelic treatments screener that...

AI is reshaping how data centers are built and powered, and chip designers like Advanced Micro Devices (AMD) sit right at the heart of that shift. With AMD’s data center revenue now more than half of its sales and management targeting strong multi year growth, investors are looking again at the broader ecosystem that feeds into AI heavy server farms. This article highlights 3 stocks from an AI driven data center expansion screener that appear positively exposed to the same forces influencing...

AECOM has secured several major infrastructure roles in Australia, Canada, and the UK. The company will act as Independent Certifier for The Wave rail project in Queensland. It has been appointed lead designer for the Alexandra Bridge replacement in Ottawa. AECOM is also the exclusive design partner for an upgrade to Thames Water’s Oxford treatment facility. AECOM (NYSE:ACM) is taking on new responsibilities across rail, bridge, and water infrastructure at a time when its stock is trading...

Nutanix (NTNX) is back in focus after GigaIO’s Gryf and Manticore systems were verified for the Nutanix Kubernetes Platform and Nutanix Enterprise AI, extending the company’s cloud platform into portable edge AI deployments. See our latest analysis for Nutanix. Nutanix’s latest edge AI partnership lands as momentum in the stock is picking up, with a 39.45% 90 day share price return and a 30 day share price return of 15.58%. This comes alongside a 1 year total shareholder return that declined...

Elevance Health (ELV) has released its Q2 2026 numbers, reporting revenue of about US$50.5b, basic EPS of US$6.71 and net income of US$1,463m. The trailing twelve months show revenue of roughly US$201.1b, EPS of US$22.53 and net income of US$4,963m. Over recent quarters the company has seen revenue move from US$49.8b in Q2 2025 to US$50.5b in Q2 2026. Over the same period, quarterly basic EPS shifted from US$7.74 to US$6.71 and net income from US$1,743m to US$1,463m, setting the backdrop for...

Edgewell Personal Care (EPC) has drawn fresh attention after recent share price gains, with the stock up over the past month and past 3 months, prompting investors to reassess its fundamentals and valuation. See our latest analysis for Edgewell Personal Care. Beyond the latest move, Edgewell Personal Care’s 28.83% 30 day share price return and 73.07% year to date share price return indicate building momentum, even though the 3 year and 5 year total shareholder returns remain negative. If...

ImmunityBio’s valuation debate has sharpened after a very strong run year to date, with the stock’s broad set of checks pointing to a mixed picture rather than a clear bargain or clear overvaluation. Year to date, ImmunityBio is up 268.8%, which puts extra focus on whether recent enthusiasm is already reflected in the share price. Speculation around an expanded commercial opportunity for Anktiva may support optimistic expectations, while uncertainty around regulatory decisions and how...

In recent months, institutional investors including Point72 Asset Management, Gotham Asset Management and GMO increased their holdings in Kimberly-Clark, signaling growing institutional interest in the company’s essential household products business. This wave of institutional accumulation highlights how Kimberly-Clark’s defensive earnings profile and resilient demand for hygiene staples is drawing capital during economic uncertainty. Next, we’ll examine how this renewed institutional...

Federal Reserve Chair Kevin Warsh’s first testimony has put monetary policy, inflation, and central bank independence back at the center of market conversations, and large cap U.S. financial stocks sit close to that action. When Fed policy is in focus, some companies can find their business models better aligned with the new playbook, while others may face tougher conditions. This article explains how the latest Fed signals and the ongoing inflation debate relate to large U.S. financials. It...

Earlier in July 2026, Molson Coors Beverage Company reported that analysts expected fiscal second-quarter earnings of US$1.52 per share, a 25.9% profit decline from the prior year, while Dimensional Fund Advisors disclosed holding 8,828,265 shares, or 5.0% of the company’s common stock. This combination of a forecast earnings drop, a mixed but generally cautious analyst stance, and a large institutional holder’s position has sharpened investor focus on how Molson Coors might balance profit...

Earlier in July 2026, Dycom Industries reported a record backlog and lifted its fiscal 2027 outlook, citing strong demand for AI-driven digital infrastructure and data center projects, alongside contributions from recent acquisitions such as Power Solutions and National Technology Integrators. This combination of expanding AI-related infrastructure work, improved profitability, and growing revenue visibility has led analysts to highlight Dycom as a top growth candidate with rising earnings...

In early July 2026, law firms Block & Leviton and Bleichmar Fonti & Auld LLP launched securities fraud actions against Planet Fitness, alleging the company misled investors about a marketing pivot that coincided with weaker-than-expected membership growth and reduced guidance. The legal scrutiny centers on whether Planet Fitness’s shift toward more fitness-focused members undermined its appeal to casual gym users, a core pillar of its business model and earlier growth story. We’ll now...

Bank of New York Mellon Corporation (BNY) opened Q2 2026 with revenue of US$5.7 billion and basic EPS of US$2.47, alongside trailing twelve month revenue of US$21.4 billion and basic EPS of US$8.66 that sit on top of a 26% earnings growth rate over the past year. The company has seen revenue move from US$18.8 billion and EPS of US$6.18 on a trailing basis in Q1 2025 to US$21.4 billion and EPS of US$8.66 by Q2 2026, while net income climbed from US$4.53 billion to US$6.02 billion over the same...

Conagra Brands (CAG) has capped FY 2026 with fourth quarter revenue of US$2,882.1 million and basic EPS of a US$3.37 loss, as trailing twelve month figures show revenue of US$11.3 billion and basic EPS of a US$4.00 loss. Over recent periods the company has seen quarterly revenue move between US$2,632.6 million and US$2,979.1 million, while basic EPS has shifted from profits of US$0.54 in FY 2025 Q4 to losses in FY 2026 Q2 and Q4. For investors, the latest results put the focus on how Conagra...

Earlier this week, W.W. Grainger was downgraded to Equal-Weight from Overweight by Stephens analyst Tommy Moll, even as management recently raised guidance on the back of resilient demand and strong operational execution. The downgrade was driven not by weakening fundamentals but by the view that Grainger’s premium valuation already reflects its earnings growth and upgraded outlook. We’ll now examine how this valuation-driven downgrade, set against upgraded guidance and expected earnings...

Aehr Test Systems (AEHR) has wrapped up FY 2026 with fourth quarter revenue of US$18.8 million and EPS of US$0.04, compared with revenue of US$14.1 million and EPS of US$0.10 loss in the prior year’s fourth quarter, while the latest trailing twelve months show revenue of US$50.0 million and an EPS loss of US$0.23. Over the past six reported quarters, the company has seen quarterly revenue range between US$9.9 million and US$18.8 million, with EPS moving between a loss of US$0.11 and a profit...

Political uncertainty around President Trump’s election-focused address, the proposed SAVE America Act, and Iran war concerns is putting fresh attention on U.S. defense and security stocks. When policy priorities, funding paths, and public sentiment all feel up in the air, investors often reassess which companies might be positioned to benefit or face added risk. This article looks at three U.S. Defense and Security Stocks from our screener that appear more positively exposed to the current...